Your browser doesn't support javascript.
Therapeutic Application of Alpha-1 Antitrypsin in COVID-19.
Ritzmann, Felix; Chitirala, Praneeth; Krüger, Nadine; Hoffmann, Markus; Zuo, Wei; Lammert, Frank; Smola, Sigrun; Tov, Naveh; Alagem, Noga; Lepper, Philipp M; Pöhlmann, Stefan; Beisswenger, Christoph; Herr, Christian; Bals, Robert.
  • Ritzmann F; Saarland University Homburg, Germany.
  • Chitirala P; Saarland University Homburg, Germany.
  • Krüger N; German Primate Center-Leibniz Institute for Primate Research Göttingen, Germany.
  • Hoffmann M; German Primate Center-Leibniz Institute for Primate Research Göttingen, Germany.
  • Zuo W; University of Göttingen Göttingen, Germany.
  • Lammert F; Tongji University Shanghai, China.
  • Smola S; Saarland University Homburg, Germany.
  • Tov N; Hannover Medical School Hannover, Germany.
  • Alagem N; Saarland University Medical Center Homburg, Germany.
  • Lepper PM; Kamada Ltd. Rehovot, Israel.
  • Pöhlmann S; Kamada Ltd. Rehovot, Israel.
  • Beisswenger C; Saarland University Homburg, Germany.
  • Herr C; German Primate Center-Leibniz Institute for Primate Research Göttingen, Germany.
  • Bals R; University of Göttingen Göttingen, Germany.
Am J Respir Crit Care Med ; 204(2): 224-227, 2021 07 15.
Article in English | MEDLINE | ID: covidwho-1219891

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alpha 1-Antitrypsin / Pandemics / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Observational study Limits: Humans Language: English Journal: Am J Respir Crit Care Med Journal subject: Critical Care Year: 2021 Document Type: Article Affiliation country: Rccm.202104-0833LE

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Alpha 1-Antitrypsin / Pandemics / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Observational study Limits: Humans Language: English Journal: Am J Respir Crit Care Med Journal subject: Critical Care Year: 2021 Document Type: Article Affiliation country: Rccm.202104-0833LE